CNTN$3.02+0.00%

Fair $3.02+0.0%

CNTN

Canton Strategic Holdings, Inc.

Healthcare / BiotechnologyNasdaqCM

$3.02

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $3.02Fund rank 29/100 · Data gapSEC 6/6 yrs|

SA 0/F

F-Score: 3/9

Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 20% · confianza 25%

FCF escenarios

weak_data · normalized FCF n/d · quality 50.0/100

Data gap 29/100

Bear 5Yn/dn/d

Base 5Yn/dn/d

Bull 5Yn/dn/d

Return 0/100Downside 20/100Model quality 50/100Data QA 35/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

0/100

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

90/100

SEC 100%

Latest source: sec-companyfactsPeriods: 6Warnings: 1sec-companyfacts: 6

Sector-specific holding-company NAV/SOTP model required: targets are disabled until look-through holdings, debt and discount data exists. ROE is -9.0%, below the 5% threshold

Thesis & Journal · CNTNLocal privado en este navegador · Canton Strategic Holdings, Inc.

Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Tesis central

Bull caseBase caseBear case

CatalizadoresRiesgos

Kill criteria

Mi valoración / targetReview date

Sin guardar todavía.

Market Cap

$171M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-9.0%

↓

Gross Margin

N/A

•

Debt/Equity

N/A

•

No hay histórico de precio usable para pintar el gráfico TradingView.

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2020–2025 · 5 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

—

FCF / Net income

—

Latest source

SEC-backed

Margin decomposition

Último año: revenue — · net income $-35.9M · FCF —

2020-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

—— pts

FCF margin

—— pts

SEC-backed annual metrics active for 2025, 2024, 2023, 2022, 2021, 2020. Local SEC Companyfacts override Yahoo/FMP for audited annual line items; provider-only fields remain as fallback.

Metric	TTM	2025SEC	2024SEC	2023SEC	2022SEC	2021SEC	2020SEC
Income Statement
Net Income	$-35.9M	$-35.9M	$-12.2M	$-9.3M	$-8.5M	$-2.2M	$-2.4M
EPS	-1.12	-1.12	-9.41	-107.02	-18.72	-0.35	—
Returns
ROE	-9.0%	-9.0%	-932.8%	-102.1%	-152.8%	-47.1%	-65.0%
Valuation
P/B	0.24	0.24	2.99	0.03	0.25	—	—
Growth & Yield
EPS Growth	88.1%	88.1%	91.2%	-471.7%	-5248.6%	—	—

Returns (%)